‘Love Hormone’ Could Hold Key to Treating COVID | Health News

By Robert Preidt, HealthDay Reporter


FRIDAY, Oct. 9, 2020 (HealthDay News) — The so-called love hormone, oxytocin, may be worth investigating as a treatment for COVID-19, a new study suggests.

One of the most serious complications of infection with the new coronavirus is a “cytokine storm,” in which the body attacks its own tissues.

There are currently no U.S. Food and Drug Administration-approved treatments for COVID-19, which means that “repurposing existing drugs that can act on the adaptive immune response and prevent the cytokine storm in early phases of the disease is a priority,” according to the researchers.

Previous research suggests that oxytocin — a hormone that’s produced in the brain and is involved in reproduction and childbirth — reduces inflammation.

In this new study, researcher Ali Imami, a graduate research assistant at the University of Toledo in Ohio, and colleagues used a U.S. National Institutes of Health database

Read More

Researchers Identify Bacteria Responsible for Key Crohn’s Complication | Health News

By Robert Preidt, HealthDay Reporter


TUESDAY, Oct. 6, 2020 (HealthDay News) — Leaking bacteria from the intestine triggers “creeping fat” that often occurs in people with Crohn’s disease, according to a new study.

Creeping fat is abdominal fat that wraps around the intestines of patients with this type of inflammatory bowel disease (IBD). It was unknown what triggered the fat to do this.

“Creeping fat is often a landmark for surgeons performing resections on an IBD patient’s bowels because they know when they see it, that’s likely where the lesions are located,” said study author Suzanne Devkota, an assistant professor of gastroenterology at Cedars-Sinai in Los Angeles.

“But we don’t know whether the presence of the fat is making the disease worse or trying to protect the intestines from something,” she added in a hospital news release.

Devkota’s team analyzed small intestine and fat tissue samples from 11 Crohn’s

Read More

Antimatter Particles Hold Key In Timely Attack Against Growing Tumors


  • A timer invented by experts permits PET scanners to attack  cancer cells in their weakest
  • The invention may pave the way to less invasive radiation treatment for cancer patients
  • Inventors hoped the technology can be made more affordable in a decade

Doctors may soon kill cancer tumors with less invasive side effects of radiation treatment. This is after a team of experts designed a scanner that can time the antimatter particles that are significant in detecting the levels of the oxygen concentration in cancer tissues. For years, medical experts have witnessed how low levels of oxygen prevented the timely killing of rapidly growing cancer cells. 

A team of Japanese atomic physicists and nuclear medicine experts designed a timer that can detect the oxygen concentration of tissues growing throughout ta cancer patient’s body. Specifically, the timer permits the positron emission tomography (PET) scanners to know when to attack the

Read More

Contract Tracing, Key to Reining in the Virus, Falls Flat in the West

LONDON — As the coronavirus stampeded across Europe and the United States this spring, governments made their depleted citizens a tantalizing promise: Soon, legions of disease detectives would hunt down anyone exposed to the virus, confining them to their homes and letting everyone else get on with their lives.

Nearly eight months on, as a web of new infections spreads across Europe and the United States, that promise has nearly evaporated.

Despite repeated vows by Western nations to develop “world-beating” testing and tracing operations, those systems have been undone by a failure of governments to support citizens through onerous quarantines or to draw out intimate details of their whereabouts. That has shattered the hope of pinpoint measures replacing lockdowns and undermined flagging confidence in governments.

Beholden to privacy rules, Western officials largely trusted people to hand over names to contact tracers. But that trust was not repaid, in large part

Read More

Rates of key tests drop with fewer doctor visits, more telemedicine amid COVID-19

Oct. 2 (UPI) — The number of in-office visits to primary care physicians in the United States were 50% lower in the spring compared with the same periods in 2018 and 2019, a study published Friday by JAMA Network Open found.

At the same time, more than 35 million telemedicine consultations — in which patients communicate with their doctors by phone or online — were held in April, May and June, a 30-fold increase over previous years, the data showed.

While some medical services can be performed remotely, rates of important tests such as blood pressure and cholesterol monitoring fell by up to 50% across the country, as the public avoided doctors’ offices and other healthcare settings because of the COVID-19 pandemic, the researchers said.

“These are large, clinically important declines involving two of the most fundamental elements of primary care — the prevention of heart attacks and strokes,” study

Read More

Diversity emerges as key challenge for coronavirus drug trials

The coronavirus pandemic has hit disproportionately hard in Black and Hispanic communities, where infection rates and death rates have reached staggering levels. 

But as scientists race to develop vaccines against the SARS-CoV-2 virus and treatments for the COVID-19 disease it causes, many trials are struggling to enroll people from those very communities.

Government and private sector scientists trying to enroll tens of thousands of Americans in a handful of studies of potential coronavirus vaccines are working overtime to reach out to underrepresented communities. But they have reported running up against rumors and misinformation in minority communities in places like Seattle and New York City, where mistrust remains deeply rooted. 

That mistrust comes from America’s long history of discrimination against minority groups, some of whom have been used as human guinea pigs for sadistic experiments.  

The U.S. Public Health Service denied treatment to 600 Black men who had syphilis, even after

Read More

Invetx Announces Completion of $25.5 Million Series A Financing and Key Appointments to Executive Team

New Investors Include Casdin Capital and Tekla Capital

Antibody Development Experts Bill Brondyk, PhD, Named Chief Scientific Officer and Colin Giles, PhD, Chief Development Officer

Invetx, a pioneer in protein-based therapeutics for animal health, announced today that it has raised an additional $10.25 million in its Series A financing, bringing the total amount to $25.5 million. New investors include Casdin Capital and funds managed by Tekla Capital Management, LLC, joining existing lead investor Anterra Capital, as well as strategic investors AbCellera Biologics and WuXi Biologics. In addition, Invetx announced the appointments of Bill Brondyk, PhD, as chief scientific officer and Colin Giles, PhD, as chief development officer to its executive team.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930005118/en/

Bill Brondyk, PhD, Named Chief Scientific Officer at Invetx (Photo: Business Wire)

“We are pleased to complete our $25.5 million Series A financing, welcoming blue-chip life science investors

Read More

What Can Healthcare Providers in the CEE region do to Attract More Healthcare Investment? Infiniti’s Experts Reveal Key Growth Drivers

The Central and Eastern Europe (CEE) healthcare sector must shift focus to creating a successful healthcare system and attracting more healthcare investments. How can healthcare providers in CEE attract more healthcare investments? According to Infiniti’s industry experts, providers must adopt advanced healthcare technologies, such as cancer screenings, electronic patient registries, improve patient mobility and accessibility to healthcare, and follow practices like outcome-based reimbursement. With Infiniti’s solutions, healthcare providers can better understand their market, how to efficiently capitalize on factors fueling growth, and create a successful system. To gain a comprehensive understanding of the CEE healthcare sector, and learn how companies can encourage more healthcare investments, request a free proposal.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930005606/en/

Three Key Factors Fueling Healthcare Investments in the CEE Region (Graphic: Business Wire)

Recently, reforming health services has become a priority on the political agenda, which has fueled growth in

Read More

Global Precision Medicine Market 2020 with (COVID-19) Impact Analysis, Product Type, Application, Key Manufacturers, Regions and Forecast to 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 29, 2020 (CDN Newswire via Comtex) —
A wide-ranging analysis report titled Global Precision Medicine Market 2020 by Company, Regions, Type and Application, Forecast to 2025 provides a brief overview of the market covering the scope, size, disposition, and growth of the industry. The report presents an estimate of the current market scenario and data related to the competitive landscape of the industry. It delivers five-year industry forecasts, growth rates, and an analysis of the industry key players and their market shares. The report shows information regards to several regions that have successfully established its position in the global Precision Medicine market. The geographical and competitive dynamics of this global market will help you get a comprehensive picture of the market.

An industrial chain, market measurements regarding revenue, sales, value, capacity, regional market examination, section insightful

Read More

Ex-Sainsbury’s boss takes key Test and Trace job

a man wearing glasses and looking at the camera

© Reuters

Former Sainsbury’s supermarket chief executive Mike Coupe is to take over as director of Covid-19 testing at England’s Test and Trace agency.

He brings huge experience in running supply chains and logistics, said the Department for Health and Social Care.

But Labour shadow health secretary Jon Ashworth said it would make more sense to put “those trained in actual infectious disease control in charge”.

Mr Coupe, who left Sainsbury’s in May, replaces Sarah-Jane Marsh.

Earlier this month she issued a “heartfelt” apology for problems with the coronavirus testing system. She blamed delays in laboratory processing.

At Test and Trace, Mr Coupe will be joining other former retail executives. The head of the service, Dido Harding, worked at Tesco and Sainsbury’s before spending seven years as boss of TalkTalk.

A former head of HR at Sainsbury’s is at test and trace, as is a former digital director of Waitrose.

Read More